— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

Royalty Pharma Sub-Manager, LLC

Q1 2026 · Filed 2026-05-14
Market Value
$148M
Holdings
3
New Purchases
0
Added To
1
Closed
0
Reduced
0
Top 10 Concentration
100.0%
Turnover
0.0%

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 1 $65M 43.7%
Small Cap 2 $83M 56.3%

Portfolio Analytics

Avg Market Cap
$4.2B
Median Market Cap
$1.7B
Avg P/E
Median P/E
Avg Dividend Yield
—%
Avg Beta
0.13
# Stocks
3
# ETFs / Funds
0

Top Holdings (3 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 CYTK 43.68% 980,392 $65M $65.91 $2M
2 BCAX 31.56% 2,388,150 $47M $19.55 $823K +1,125,000 +89.1%
3 BCRX 24.75% 3,846,154 $37M $9.52 $7M
View SEC EDGAR Filings for Royalty Pharma Sub-Manager, LLC →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms